Research & Development

The persistent feeling of being physically older and less resilient following a serious illness is no longer just a subjective complaint but is now understood as a tangible biological process driven by cellular damage. Many who recover from infections like influenza or COVID-19 report lingering

We are joined by biopharma expert Ivan Kairatov to discuss a groundbreaking discovery that redefines our understanding of IDH-mutant glioma, the most common malignant brain tumor in young adults. This conversation explores how this cancer begins not as a visible mass, but as a stealthy infiltration

A comprehensive analysis of recent oncological research has illuminated a remarkably promising therapeutic strategy for hepatocellular carcinoma (HCC), a notoriously aggressive and increasingly prevalent form of liver cancer. This investigation centers on the synergistic application of two natural

A significant portion of cancer patients do not respond to immunotherapy because their tumors are immunologically inactive, but a groundbreaking collaborative study from Cornell University researchers has unveiled a remarkable solution using ultrasmall fluorescent silica nanoparticles, known as

For the millions of people battling chronic nerve pain, where the lightest touch can feel like a searing burn, hope often feels distant. But a groundbreaking study is challenging the way we think about pain, shifting the focus from masking symptoms to repairing the damage at a cellular level. To

A groundbreaking therapy capable of halting one of the most aggressive forms of cancer has long been shadowed by a side effect so severe that it forces patients to abandon their best hope for survival. This paradox has defined the initial chapter of PSMA-targeted radioligand therapy, a significant